Cardio Diagnostics Holdings (CDIO) Total Debt (2022)
Cardio Diagnostics Holdings (CDIO) posted Total Debt of $433334.0 for Q3 2022.
Cardio Diagnostics Holdings (CDIO) Total Debt (2022) Analysis & Trends
Cardio Diagnostics Holdings has reported Total Debt for 1 years, with the latest figure at $433334.0 in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 9.34 Bn |
| 10 | Cardio Diagnostics Holdings | 6.07 Mn | 480,214.31 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 433,334.00 |